Neil Gibson
Directeur/Membre du Conseil chez INSTIL BIO, INC.
Fortune : 515 846 $ au 30/04/2024
Postes actifs de Neil Gibson
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SHATTUCK LABS, INC. | Directeur/Membre du Conseil | 01/11/2016 | - |
| Independent Dir/Board Member | 01/11/2016 | - | |
| INSTIL BIO, INC. | Directeur/Membre du Conseil | 01/06/2020 | - |
| Independent Dir/Board Member | 01/03/2021 | - | |
Cullinan MICA, Inc.
 Cullinan MICA, Inc. Investment ManagersFinance Cullinan MICA, Inc. develops immune-oncology antibody. The company is headquartered in the United States. | Directeur/Membre du Conseil | 01/01/2020 | - |
Causeway Therapeutics Ltd.
 Causeway Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Causeway Therapeutics Ltd. operates as a biotechnology company. It develops drugs for the treatment for patients. The company was founded by Derek S. Gilchrist and Neal L. Millar and is headquartered in Glasgow, the United States. | Directeur/Membre du Conseil | - | - |
Silarus Therapeutics, Inc.
 Silarus Therapeutics, Inc. BiotechnologyHealth Technology Silarus Therapeutics, Inc. develops therapeutics targeting erythroferrone for the treatment of iron deficiency and iron overload disorders. The company was founded by Tomas Ganz, Sanford J. Madigan, and Elizabeta Nemeth in May 19, 2014 and is headquartered in La Jolla, CA. | Directeur Technique/Scientifique/R&D | - | - |
Cullinan Mica Corp.
 Cullinan Mica Corp. Pharmaceuticals: MajorHealth Technology Part of Cullinan Therapeutics, Inc., Cullinan Mica Corp. is a company that provides worldwide rights to CLN-619. The company is based in Cambridge, MA. The CEO of the company is Nadim Ahmed. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Neil Gibson
Anciens postes connus de Neil Gibson
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| TCR2 THERAPEUTICS INC. | Directeur/Membre du Conseil | 01/02/2018 | 01/06/2023 |
| Independent Dir/Board Member | 01/02/2018 | 01/06/2023 | |
COI Pharmaceuticals, Inc.
 COI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology COI Pharmaceuticals, Inc. provides life science investors. It offers research and development infrastructure and industry mentors to the portfolio companies of Avalon Ventures. The company was founded in 2013 and is headquartered in La Jolla, CA. | Directeur Technique/Scientifique/R&D | 01/10/2016 | 01/12/2021 |
Adanate, Inc.
 Adanate, Inc. BiotechnologyHealth Technology Adanate, Inc. develops antibody therapeutics. The CEO of the American company is Chris Griffith. | Directeur/Membre du Conseil | 01/01/2021 | 02/11/2021 |
| Directeur Général | 01/01/2017 | - | |
| President | 01/01/2017 | - | |
| ░░░░░░░░ ░░░░ ░░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░ | - | - |
| ░░░░░░░░░░ ░░ ░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Formation de Neil Gibson
| University of Aston | Doctorate Degree |
| University of Strathclyde | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 16 |
| Royaume-Uni | 5 |
| Allemagne | 2 |
Opérationnelle
| Director/Board Member | 8 |
| Chief Tech/Sci/R&D Officer | 4 |
| Corporate Officer/Principal | 4 |
Sectorielle
| Health Technology | 15 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 6 |
|---|---|
| REGULUS THERAPEUTICS INC. | Health Technology |
| BAYER AG | Health Technology |
| BIOATLA, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| SHATTUCK LABS, INC. | Health Technology |
| INSTIL BIO, INC. | Health Technology |
| Entreprise privées | 11 |
|---|---|
OSI Pharmaceuticals, Inc.
 OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OSI Pharmaceuticals, Inc. manufactured and develope dpharmaceutical drugs. The company was founded in 1983 and was headquartered in Farmingdale, NY. | Health Technology |
COI Pharmaceuticals, Inc.
COI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology COI Pharmaceuticals, Inc. provides life science investors. It offers research and development infrastructure and industry mentors to the portfolio companies of Avalon Ventures. The company was founded in 2013 and is headquartered in La Jolla, CA. | Health Technology |
TCR2 Therapeutics, Inc.
 TCR2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology TCR2 Therapeutics, Inc. is a clinical-stage cell therapy company, which engages in the development of biological drugs and engineering T-cells for cancer therapy. It is also involved in the research and collaboration with academic laboratories and industry partners in the field of T-cell immunology, cell therapy, gene editing, and process development. The company was founded by Patrick A. Baeuerle on May 29, 2015 and is headquartered in Cambridge, MA. | Health Technology |
CytoSen Therapeutics, Inc.
 CytoSen Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services CytoSen Therapeutics, Inc. develops natural killer (NK) cell therapeutics for cancer. It offers nanoparticle processing technology which enables improved ex vivo expansion and activation of NK-cells supporting multiple high dose infusions with anti-cancer cytotoxicity. The company was founded by Stefan O. Ciurea, Dean Lee and Robert Igarashi and is headquartered in Orlando, FL. | Commercial Services |
Cullinan Mica Corp.
 Cullinan Mica Corp. Pharmaceuticals: MajorHealth Technology PDI Therapeutics, Inc. develops therapeutics that enhances the body’s ability to recognize and destroy tumor cells. The company is headquartered in La Jolla, CA. | Health Technology |
Adanate, Inc.
Adanate, Inc. BiotechnologyHealth Technology Adanate, Inc. develops antibody therapeutics. The CEO of the American company is Chris Griffith. | Health Technology |
Silarus Therapeutics, Inc.
Silarus Therapeutics, Inc. BiotechnologyHealth Technology Silarus Therapeutics, Inc. develops therapeutics targeting erythroferrone for the treatment of iron deficiency and iron overload disorders. The company was founded by Tomas Ganz, Sanford J. Madigan, and Elizabeta Nemeth in May 19, 2014 and is headquartered in La Jolla, CA. | Health Technology |
| British Pharmaceutical Students Association | |
Causeway Therapeutics Ltd.
Causeway Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Causeway Therapeutics Ltd. operates as a biotechnology company. It develops drugs for the treatment for patients. The company was founded by Derek S. Gilchrist and Neal L. Millar and is headquartered in Glasgow, the United States. | Health Technology |
Cullinan MICA, Inc.
Cullinan MICA, Inc. Investment ManagersFinance Cullinan MICA, Inc. develops immune-oncology antibody. The company is headquartered in the United States. | Finance |
Cullinan Mica Corp.
Cullinan Mica Corp. Pharmaceuticals: MajorHealth Technology Part of Cullinan Therapeutics, Inc., Cullinan Mica Corp. is a company that provides worldwide rights to CLN-619. The company is based in Cambridge, MA. The CEO of the company is Nadim Ahmed. | Health Technology |
- Bourse
- Insiders
- Neil Gibson
- Expérience
